(TMHC) Taylor Morn Home - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87724P1066
Stock: Homes, Communities, Build-To-Rent, Financial Services
Total Rating 38
Risk 60
Buy Signal -0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -20.85 |
| Character TTM | |
|---|---|
| Beta | 0.960 |
| Beta Downside | 1.690 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.90% |
| CAGR/Max DD | 0.68 |
EPS (Earnings per Share)
Revenue
Description: TMHC Taylor Morn Home February 25, 2026
Taylor Morrison Home Corp. (TMHC) is a U.S. homebuilder and land developer that designs, constructs and sells single-family and multifamily homes across entry-level, move-up and resort markets under the Taylor Morrison, Esplanade and Yardly brands. In addition to building, the company provides title insurance, closing settlement services and other financial solutions, and it operates a Build-to-Rent platform through Yardly.
For the fiscal year ended 2023, TMHC reported revenue of roughly $6.3 billion and delivered 12,300 homes, with an average selling price of $388 k-up 5% year-over-year as housing demand outpaces new supply. The firm’s backlog stood at $6.8 billion, supporting earnings guidance through 2025, while its net profit margin expanded to 6.5% after cost-control initiatives. Macro-level drivers remain strong: U.S. housing starts rose 3% YoY and mortgage rates have stabilized around 5.5%, keeping affordability pressures manageable for its target buyer segments.
For deeper insight, you may want to explore TMHC’s profile on ValueRay.
Headlines to watch out for
- Mortgage rate fluctuations impact new home demand
- Lumber and labor costs pressure homebuilding margins
- Land acquisition and development costs affect profitability
- Economic recession reduces consumer confidence in housing
- Local zoning and environmental regulations influence project timelines
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 785.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 6.19 > 1.0 |
| NWC/Revenue: 73.82% < 20% (prev 82.79%; Δ -8.97% < -1%) |
| CFO/TA 0.09 > 3% & CFO 839.1m > Net Income 785.2m |
| Net Debt (1.51b) to EBITDA (1.16b): 1.30 < 3 |
| Current Ratio: 6.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (98.7m) vs 12m ago -7.01% < -2% |
| Gross Margin: 23.20% > 18% (prev 0.25%; Δ 2.30k % > 0.5%) |
| Asset Turnover: 84.89% > 50% (prev 87.86%; Δ -2.97% > 0%) |
| Interest Coverage Ratio: 24.22 > 6 (EBITDA TTM 1.16b / Interest Expense TTM 47.0m) |
Altman Z'' 9.93
| A: 0.61 (Total Current Assets 7.14b - Total Current Liabilities 1.14b) / Total Assets 9.84b |
| B: 0.53 (Retained Earnings 5.18b / Total Assets 9.84b) |
| C: 0.12 (EBIT TTM 1.14b / Avg Total Assets 9.57b) |
| D: 3.26 (Book Value of Equity 11.49b / Total Liabilities 3.53b) |
| Altman-Z'' Score: 9.93 = AAA |
Beneish M -2.34
| DSRI: 1.12 (Receivables 241.7m/217.7m, Revenue 8.12b/8.17b) |
| GMI: 1.06 (GM 23.20% / 24.68%) |
| AQI: 1.91 (AQ_t 0.24 / AQ_t-1 0.13) |
| SGI: 0.99 (Revenue 8.12b / 8.17b) |
| TATA: -0.01 (NI 785.2m - CFO 839.1m) / TA 9.84b) |
| Beneish M-Score: -2.34 (Cap -4..+1) = BBB |
What is the price of TMHC shares?
As of March 12, 2026, the stock is trading at USD 60.24 with a total of 725,966 shares traded.
Over the past week, the price has changed by -6.25%, over one month by -9.35%, over three months by -5.51% and over the past year by -1.46%.
Over the past week, the price has changed by -6.25%, over one month by -9.35%, over three months by -5.51% and over the past year by -1.46%.
Is TMHC a buy, sell or hold?
Taylor Morn Home has received a consensus analysts rating of 4.30.
Therefore, it is recommended to buy TMHC.
- StrongBuy: 4
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TMHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.9 | 24.3% |
| Analysts Target Price | 74.9 | 24.3% |
TMHC Fundamental Data Overview March 08, 2026
P/E Trailing = 7.9339
P/E Forward = 11.9617
P/S = 0.7265
P/B = 0.9432
P/EG = 1.511
Revenue TTM = 8.12b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 1.16b USD
Long Term Debt = 2.29b USD (from longTermDebt, last quarter)
Short Term Debt = 82.6m USD (from shortTermDebt, last quarter)
Debt = 2.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.51b USD (from netDebt column, last quarter)
Enterprise Value = 7.41b USD (5.90b + Debt 2.36b - CCE 850.0m)
Interest Coverage Ratio = 24.22 (Ebit TTM 1.14b / Interest Expense TTM 47.0m)
EV/FCF = 9.28x (Enterprise Value 7.41b / FCF TTM 798.8m)
FCF Yield = 10.78% (FCF TTM 798.8m / Enterprise Value 7.41b)
FCF Margin = 9.84% (FCF TTM 798.8m / Revenue TTM 8.12b)
Net Margin = 9.67% (Net Income TTM 785.2m / Revenue TTM 8.12b)
Gross Margin = 23.20% ((Revenue TTM 8.12b - Cost of Revenue TTM 6.24b) / Revenue TTM)
Gross Margin QoQ = 22.04% (prev 22.74%)
Tobins Q-Ratio = 0.75 (Enterprise Value 7.41b / Total Assets 9.84b)
Interest Expense / Debt = 0.50% (Interest Expense 11.9m / Debt 2.36b)
Taxrate = 22.26% (50.7m / 227.8m)
NOPAT = 884.9m (EBIT 1.14b * (1 - 22.26%))
Current Ratio = 6.24 (Total Current Assets 7.14b / Total Current Liabilities 1.14b)
Debt / Equity = 0.37 (Debt 2.36b / totalStockholderEquity, last quarter 6.31b)
Debt / EBITDA = 1.30 (Net Debt 1.51b / EBITDA 1.16b)
Debt / FCF = 1.89 (Net Debt 1.51b / FCF TTM 798.8m)
Total Stockholder Equity = 6.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.21% (Net Income 785.2m / Total Assets 9.84b)
RoE = 12.83% (Net Income TTM 785.2m / Total Stockholder Equity 6.12b)
RoCE = 13.53% (EBIT 1.14b / Capital Employed (Equity 6.12b + L.T.Debt 2.29b))
RoIC = 10.68% (NOPAT 884.9m / Invested Capital 8.28b)
WACC = 6.86% (E(5.90b)/V(8.26b) * Re(9.45%) + D(2.36b)/V(8.26b) * Rd(0.50%) * (1-Tc(0.22)))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.85%
[DCF] Terminal Value 82.35% ; FCFF base≈550.8m ; Y1≈546.7m ; Y5≈570.1m
[DCF] Fair Price = 118.3 (EV 12.91b - Net Debt 1.51b = Equity 11.40b / Shares 96.3m; r=6.86% [WACC]; 5y FCF grow -1.47% → 2.90% )
EPS Correlation: 15.15 | EPS CAGR: 7.82% | SUE: 1.10 | # QB: 2
Revenue Correlation: 25.66 | Revenue CAGR: 5.74% | SUE: 2.21 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.30 | Chg7d=+0.001 | Chg30d=-0.236 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=5.15 | Chg7d=+0.042 | Chg30d=-1.325 | Revisions Net=-4 | Growth EPS=-37.5% | Growth Revenue=-17.5%
EPS next Year (2027-12-31): EPS=6.52 | Chg7d=+0.099 | Chg30d=-1.434 | Revisions Net=-1 | Growth EPS=+26.6% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.2% (Discount Rate 9.4% - Earnings Yield 12.6%)
[Growth] Growth Spread = -12.3% (Analyst -15.5% - Implied -3.2%)
P/E Forward = 11.9617
P/S = 0.7265
P/B = 0.9432
P/EG = 1.511
Revenue TTM = 8.12b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 1.16b USD
Long Term Debt = 2.29b USD (from longTermDebt, last quarter)
Short Term Debt = 82.6m USD (from shortTermDebt, last quarter)
Debt = 2.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.51b USD (from netDebt column, last quarter)
Enterprise Value = 7.41b USD (5.90b + Debt 2.36b - CCE 850.0m)
Interest Coverage Ratio = 24.22 (Ebit TTM 1.14b / Interest Expense TTM 47.0m)
EV/FCF = 9.28x (Enterprise Value 7.41b / FCF TTM 798.8m)
FCF Yield = 10.78% (FCF TTM 798.8m / Enterprise Value 7.41b)
FCF Margin = 9.84% (FCF TTM 798.8m / Revenue TTM 8.12b)
Net Margin = 9.67% (Net Income TTM 785.2m / Revenue TTM 8.12b)
Gross Margin = 23.20% ((Revenue TTM 8.12b - Cost of Revenue TTM 6.24b) / Revenue TTM)
Gross Margin QoQ = 22.04% (prev 22.74%)
Tobins Q-Ratio = 0.75 (Enterprise Value 7.41b / Total Assets 9.84b)
Interest Expense / Debt = 0.50% (Interest Expense 11.9m / Debt 2.36b)
Taxrate = 22.26% (50.7m / 227.8m)
NOPAT = 884.9m (EBIT 1.14b * (1 - 22.26%))
Current Ratio = 6.24 (Total Current Assets 7.14b / Total Current Liabilities 1.14b)
Debt / Equity = 0.37 (Debt 2.36b / totalStockholderEquity, last quarter 6.31b)
Debt / EBITDA = 1.30 (Net Debt 1.51b / EBITDA 1.16b)
Debt / FCF = 1.89 (Net Debt 1.51b / FCF TTM 798.8m)
Total Stockholder Equity = 6.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.21% (Net Income 785.2m / Total Assets 9.84b)
RoE = 12.83% (Net Income TTM 785.2m / Total Stockholder Equity 6.12b)
RoCE = 13.53% (EBIT 1.14b / Capital Employed (Equity 6.12b + L.T.Debt 2.29b))
RoIC = 10.68% (NOPAT 884.9m / Invested Capital 8.28b)
WACC = 6.86% (E(5.90b)/V(8.26b) * Re(9.45%) + D(2.36b)/V(8.26b) * Rd(0.50%) * (1-Tc(0.22)))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.85%
[DCF] Terminal Value 82.35% ; FCFF base≈550.8m ; Y1≈546.7m ; Y5≈570.1m
[DCF] Fair Price = 118.3 (EV 12.91b - Net Debt 1.51b = Equity 11.40b / Shares 96.3m; r=6.86% [WACC]; 5y FCF grow -1.47% → 2.90% )
EPS Correlation: 15.15 | EPS CAGR: 7.82% | SUE: 1.10 | # QB: 2
Revenue Correlation: 25.66 | Revenue CAGR: 5.74% | SUE: 2.21 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.30 | Chg7d=+0.001 | Chg30d=-0.236 | Revisions Net=-2 | Analysts=7
EPS current Year (2026-12-31): EPS=5.15 | Chg7d=+0.042 | Chg30d=-1.325 | Revisions Net=-4 | Growth EPS=-37.5% | Growth Revenue=-17.5%
EPS next Year (2027-12-31): EPS=6.52 | Chg7d=+0.099 | Chg30d=-1.434 | Revisions Net=-1 | Growth EPS=+26.6% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.2% (Discount Rate 9.4% - Earnings Yield 12.6%)
[Growth] Growth Spread = -12.3% (Analyst -15.5% - Implied -3.2%)